Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01099696 · ClinicalTrials.gov registry record · NA
Study to Evaluate a Probiotic in Healthy Subjects With a History of Abdominal Discomfort and Bloating
A NA study of Bloating and Abdominal Discomfort, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 302
- Enrollment target
- 10
- Study locations
NCT01099696: Completed NA study of Bloating and Abdominal Discomfort, sponsored by Procter and Gamble.
NCT01099696 is a NA study of Bloating and Abdominal Discomfort that has completed, run by Procter and Gamble. The registered enrollment target is 302 participants, above the 43-participant average among 5 other Bloating trials with a reported enrollment target (602% higher). The trial reports 10 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01099696, a NA study of Bloating and Abdominal Discomfort, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 302 participants
- Enrollment target
- 10
- Study locations
Study Summary
This is a multicenter, double-blind, randomized, placebo-controlled, 6-week study of a probiotic for abdominal discomfort and bloating in healthy subjects.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT placebo
- DIETARY_SUPPLEMENT B. infantis 35624
Study Locations (10)
Illinois
- Research Site - Chicago
- Research Site - Rockford
North Carolina
- Research Site - Chapel Hill
- Research Site - Greensboro
Indiana
- Research Site - Indianapolis
Maryland
- Research Site - Chevy Chase
Ohio
- Research Site - Cincinnati
South Carolina
- Research Site - Greer
Tennessee
- Research Site - Nashville
Virginia
- Research Site - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2010-04 |
| Est. Completion | 2010-10 |
| Phase | NA |
What the finished NCT01099696 record still lists
NCT01099696 is an interventional study that assigns participants to a tested intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap, above the 43-participant average among 5 other Bloating trials with a reported enrollment target (602% higher).
The record links to 2 conditions, with Bloating appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT01099696 lists 10 locations in 8 states (Illinois, North Carolina, Indiana).
Frequently Asked Questions
What is clinical trial NCT01099696 about?
NCT01099696 is a clinical study titled "Study to Evaluate a Probiotic in Healthy Subjects With a History of Abdominal Discomfort and Bloating". This is a multicenter, double-blind, randomized, placebo-controlled, 6-week study of a probiotic for abdominal discomfort and bloating in healthy subjects.
What is the current status of trial NCT01099696?
This trial is currently completed. It is a NA study. The enrollment target is 302 participants. The study started on 2010-04. Estimated completion is 2010-10.
What conditions does trial NCT01099696 study?
This clinical trial studies the following conditions: Bloating, Abdominal Discomfort.
What interventions are being tested in trial NCT01099696?
The interventions under investigation include: placebo (DIETARY_SUPPLEMENT), B. infantis 35624 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01099696?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01099696 being conducted?
This trial has 10 study locations across Illinois, Indiana, Maryland, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bloating
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Diaphragmatic Breathing for the Treatment of Bloating and Distension
RECRUITING · NA
-
Impact of the Inno Cleanse Dietary Supplement on Gut Health and Associated Variables in Healthy Men and Women
RECRUITING · NA
-
Treatment of Symptomatic Bloating Using a Novel Hypnotherapy Protocol
COMPLETED · NA
-
A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis
RECRUITING · Phase 2
-
A Study to Evaluate OPTI-BIOME™ Bacillus Subtilis MB40 on Abdominal Discomfort, Gas and Bloating in a Healthy Population
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia